What's Happening?
Bridge to Life Ltd., a company specializing in organ preservation and perfusion technologies, is set to present several oral presentations at the 2026 Annual Meeting of the American Transplant Congress (ATC) in Boston, Massachusetts. The event, scheduled
from June 20-24, 2026, will feature discussions on Hypothermic Oxygenated Perfusion (HOPE) technology, which is used in human uterus and small intestine transplants. The presentations will include a plenary session comparing HOPE with normothermic oxygenated perfusion. Key speakers from the Cleveland Clinic and other institutions will discuss the latest advancements in organ preservation, including the use of donor serum FMN to predict outcomes after liver transplantation. The symposium aims to connect clinical evidence with real-world implementation, focusing on the economic and operational realities of adopting perfusion technologies at scale.
Why It's Important?
The presentations by Bridge to Life at the ATC highlight significant advancements in organ preservation technology, which could improve the viability and success rates of organ transplants. This is crucial for the medical community as it seeks to expand the donor pool and enhance the quality of grafts. The adoption of technologies like HOPE could lead to better patient outcomes and more efficient use of available organs, addressing the ongoing challenge of organ shortages. The discussions at the symposium will also explore the economic implications of these technologies, potentially influencing healthcare policies and practices related to organ transplantation.
What's Next?
Following the presentations, the medical community may see increased interest in the adoption of HOPE technology and other advanced perfusion methods. This could lead to further research and trials to validate the effectiveness of these technologies in different transplant scenarios. Healthcare providers and transplant centers might consider integrating these innovations into their practices, potentially leading to policy changes and new guidelines for organ preservation and transplantation.
